Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOBOCERTINIB vs MOCLOBEMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOBOCERTINIB vs MOCLOBEMIDE: Safety Overview

Metric MOBOCERTINIB MOCLOBEMIDE
Total FAERS Reports 715 461
Deaths Reported 320 76
Death Rate 44.8% 16.5%
Hospitalizations 227 133
Average Patient Age 65.7 yrs 52.0 yrs
% Female Patients 66.1% 48.7%
FDA Approval Date Sep 15, 2021 N/A
Marketing Status Discontinued N/A